Love Reginald

SEC Form 4 insider trading activity

Love Reginald has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.

On the most recent filing, Love Reginald is listed as Director at Strata Critical Medical, Inc. Inside the rolling window, Love Reginald reported no open-market purchases and 3 open-market sales totaling $125K in SRTA. The largest disclosed transaction in the window is a sale of 11,000 SRTA shares on Nov 20, 2025, worth $48K.

Companies traded

Other insiders at SRTA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$125K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
SRTASale$29KAug 13SEC ↗
SRTASale$48KNov 24SEC ↗
SRTASale$47KNov 20SEC ↗
Showing 1–3 of 3
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Love Reginald made?

Love Reginald has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.

Which companies does Love Reginald trade?

Love Reginald has filed SEC Form 4 disclosures for 1 company, including SRTA.

When was Love Reginald's most recent SEC Form 4 filing?

Love Reginald's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.

What is Love Reginald's total buy and sell value in the current window?

Inside the rolling retention window, Love Reginald bought $0 and sold $125K based on SEC Form 4 filings.

What was Love Reginald's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 11,000 SRTA shares on 2025-11-20, worth $48K, per SEC Form 4 filings.